Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis

The problem of valproate-induced adverse drug reactions, including valproate-induced parkinsonism is of high relevance due to the widespread use of valproates in psychiatric and neurological practice and the complexity of the pathogenesis of dopaminergic neurotransmission disorders. Unfortunately, p...

Full description

Saved in:
Bibliographic Details
Main Authors: N. A. Shnayder, V. V. Grechkina, M. Y. Kissin, R. F. Nasyrova
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2025-06-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
Online Access:https://www.bekhterevreview.com/jour/article/view/1133
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839590877677223936
author N. A. Shnayder
V. V. Grechkina
M. Y. Kissin
R. F. Nasyrova
author_facet N. A. Shnayder
V. V. Grechkina
M. Y. Kissin
R. F. Nasyrova
author_sort N. A. Shnayder
collection DOAJ
description The problem of valproate-induced adverse drug reactions, including valproate-induced parkinsonism is of high relevance due to the widespread use of valproates in psychiatric and neurological practice and the complexity of the pathogenesis of dopaminergic neurotransmission disorders. Unfortunately, personalized algorithms for practicing physicians based on the use of modern methods of pharmacogenomics and pharmacometabolomics of valproate-induced parkinsonism have not yet been developed. The most important methods of diagnosis and prognosis of valproate-induced parkinsonism are 1) investigation of neurologic status (assessment of motor and non-motor symptoms of drug-induced parkinsonism); 2) therapeutic drug monitoring of total and free fractions of valproic acid; 3) study of the level of toxic metabolic metabolites of valproic acid in blood and urine; pharmacogenetic testing of non-functional single nucleotide variants of genes encoding key metabolic enzymes and key transport proteins of valproic acid efflux across the blood-brain barrier.
format Article
id doaj-art-f566d3bbcec4493cbec0c5c6f3c0f74e
institution Matheson Library
issn 2313-7053
2713-055X
language Russian
publishDate 2025-06-01
publisher Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
record_format Article
series Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
spelling doaj-art-f566d3bbcec4493cbec0c5c6f3c0f74e2025-08-03T13:06:39ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2025-06-01592405110.31363/2313-7053-2025-2-951606Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosisN. A. Shnayder0V. V. Grechkina1M. Y. Kissin2R. F. Nasyrova3V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; V.F. Voyno-Yasenetsky Krasnoyarsk State Medical UniversityV.M. Bekhterev National Medical Research Center for Psychiatry and NeurologyPavlov First St. Petersburg State Medical UniversityV.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; Tula State UniversityThe problem of valproate-induced adverse drug reactions, including valproate-induced parkinsonism is of high relevance due to the widespread use of valproates in psychiatric and neurological practice and the complexity of the pathogenesis of dopaminergic neurotransmission disorders. Unfortunately, personalized algorithms for practicing physicians based on the use of modern methods of pharmacogenomics and pharmacometabolomics of valproate-induced parkinsonism have not yet been developed. The most important methods of diagnosis and prognosis of valproate-induced parkinsonism are 1) investigation of neurologic status (assessment of motor and non-motor symptoms of drug-induced parkinsonism); 2) therapeutic drug monitoring of total and free fractions of valproic acid; 3) study of the level of toxic metabolic metabolites of valproic acid in blood and urine; pharmacogenetic testing of non-functional single nucleotide variants of genes encoding key metabolic enzymes and key transport proteins of valproic acid efflux across the blood-brain barrier.https://www.bekhterevreview.com/jour/article/view/1133valproic acidextrapyramidal disordersvalproate-induced parkinsonismpersonalized neurologypersonalized psychiatrypharmacogenetics
spellingShingle N. A. Shnayder
V. V. Grechkina
M. Y. Kissin
R. F. Nasyrova
Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
valproic acid
extrapyramidal disorders
valproate-induced parkinsonism
personalized neurology
personalized psychiatry
pharmacogenetics
title Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
title_full Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
title_fullStr Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
title_full_unstemmed Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
title_short Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
title_sort valproate induced disorders of dopamine metabolism and the development of valproate induced parkinsonism a new perspective on prevention and diagnosis
topic valproic acid
extrapyramidal disorders
valproate-induced parkinsonism
personalized neurology
personalized psychiatry
pharmacogenetics
url https://www.bekhterevreview.com/jour/article/view/1133
work_keys_str_mv AT nashnayder valproateinduceddisordersofdopaminemetabolismandthedevelopmentofvalproateinducedparkinsonismanewperspectiveonpreventionanddiagnosis
AT vvgrechkina valproateinduceddisordersofdopaminemetabolismandthedevelopmentofvalproateinducedparkinsonismanewperspectiveonpreventionanddiagnosis
AT mykissin valproateinduceddisordersofdopaminemetabolismandthedevelopmentofvalproateinducedparkinsonismanewperspectiveonpreventionanddiagnosis
AT rfnasyrova valproateinduceddisordersofdopaminemetabolismandthedevelopmentofvalproateinducedparkinsonismanewperspectiveonpreventionanddiagnosis